Implanet S.A. (EPA:ALIMP)
0.1935
-0.0055 (-2.76%)
At close: Nov 28, 2025
Implanet Market Cap
Implanet has a market cap or net worth of €24.3 million as of November 28, 2025. Its market cap has increased by 52.53% in one year.
Market Cap
24.30M
Enterprise Value
29.92M
Revenue
11.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19
Market Cap Chart
Since November 25, 2013, Implanet's market cap has decreased from 107.08M to 24.30M, a decrease of -77.30%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 24.30M | 70.60% |
| Dec 31, 2024 | 14.25M | 442.72% |
| Dec 29, 2023 | 2.62M | -47.64% |
| Dec 30, 2022 | 5.01M | 23.77% |
| Dec 31, 2021 | 4.05M | -24.18% |
| Dec 31, 2020 | 5.34M | 16.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.39B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 19.75B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.40B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.09B |